Louisiana 2022 Regular Session

Louisiana Senate Bill SB257

Introduced
3/3/22  
Introduced
3/3/22  
Refer
3/3/22  
Refer
3/3/22  
Refer
3/14/22  
Report Pass
4/6/22  
Report Pass
4/6/22  
Engrossed
4/11/22  
Engrossed
4/11/22  
Refer
4/12/22  
Refer
4/12/22  
Report Pass
5/10/22  
Report Pass
5/10/22  
Enrolled
5/26/22  
Enrolled
5/26/22  
Chaptered
5/31/22  
Chaptered
5/31/22  
Passed
5/31/22  

Caption

Provides relative to Medicaid coverage for continuous glucose monitors. (8/1/22)

Impact

The implementation of SB 257 could significantly alter the landscape of Medicaid services in Louisiana, particularly for individuals with diabetes and related conditions. By requiring regular check-ups to assess the ongoing necessity of the glucose monitors, it introduces a structured approach to healthcare management that encourages patients to engage with their healthcare providers. Such measures may lead to better health outcomes and reduce long-term medical costs associated with unmanaged diabetes.

Summary

Senate Bill 257 focuses on expanding Medicaid coverage for continuous glucose monitors for specific conditions, such as diabetes requiring insulin or glycogen storage disease type 1a. By mandating coverage for these monitors, the legislation aims to enhance the management of these medical conditions and improve the quality of care provided to eligible enrollees. This move is expected to benefit individuals relying on continuous monitoring to manage their glucose levels effectively, reflecting a commitment to supporting those with chronic health issues.

Sentiment

The legislative sentiment surrounding SB 257 appears overwhelmingly positive. The bill passed the House unanimously with a vote of 98-0, indicating strong bipartisan support. Stakeholders likely view this measure as a vital step toward enhancing Medicaid services and promoting better health management for vulnerable populations. However, discussions may arise around the administrative implications for the Louisiana Department of Health in implementing these coverage requirements.

Contention

While there appears to be broad support, potential points of contention could arise regarding the costs associated with expanding Medicaid coverage. Questions may be raised about how the Louisiana Department of Health will manage this inclusion within existing budgetary constraints. Further, the requirement for regular follow-ups may prompt discussions about access to care for enrollees, especially in rural areas where healthcare providers may be limited.

Companion Bills

No companion bills found.

Previously Filed As

LA HB1008

To Modify The Coverage Of Continuous Glucose Monitors In The Arkansas Medicaid Program.

LA H0967

Medicaid Coverage of Continuous Glucose Monitors

LA SB576

To Amend The Coverage Of Continuous Glucose Monitors Within The Arkansas Medicaid Program.

LA HB3380

Relating to continuous glucose monitors.

LA HB1061

To Ensure That Individuals With Gestational Diabetes Are Provided Coverage For Continuous Glucose Monitors Under The Arkansas Medicaid Program.

LA H1465

Continuous Glucose Monitors

LA HB648

Relative to insurance coverage for glucose monitoring.

LA HB1571

Relative to requiring insurance coverage for glucose monitoring devices for people with diabetes.

LA A3768

Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.

LA SB3414

INS-CONTINUOUS GLUCOSE MONITOR

Similar Bills

No similar bills found.